Certain uses of chemicals deemed to pose a “high concern” for endocrine disruption would be banned under legislation introduced July 13 by Sen. John Kerry (D-Mass.) and Rep. Jim Moran (D-Va.).
The Endocrine Disrupting Chemicals Exposure Elimination Act (bill number not yet assigned) would establish a research program for endocrine disruptors and an expert panel to study up to 10 potential disruptors annually to rank them as posing high, substantial, minimal, or no concern. It also would mandate a federal exposure-reduction strategy for chemicals of concern.
The exposure-reduction strategy would make it unlawful to use a “high concern” chemical “in interstate commerce or in a manner that affects interstate commerce, unless the pathway to human exposure is mitigated before or in conjunction with that use.”
Endocrine disruptors are chemicals that mimic, block, or alter the function of hormones.
In a printed statement, Moran said: “When one in every six children has been diagnosed with some type of developmental disability, serious questions arise about whether something is wrong with our environment.
“We owe it to future generations to solve this puzzle. The bill introduced today will expedite research on endocrine-disrupting chemicals and allow that science, not politics, to guide policies.”
The legislation would require the director of the National Institute of Environmental Health Sciences (NIEHS) to establish a research program within the National Toxicology Program, which the institute manages.
The research program would study the full range of potential human health effects of endocrine disruptors and design tests that are sufficiently sensitive to identify chemicals capable of disrupting the human endocrine system.
An expert panel convened by the NIEHS director would review as many as 10 chemicals a year to determine their endocrine effects and rank them as posing high, substantial, minimal, or no concerns.
The NIEHS director would prepare a list of the chemicals and the concern level they pose on a biennial basis.
Federal agencies with regulatory authority over any chemical on the list would be required to develop a strategy for reducing human exposure to it if the chemical was ranked with a minimal level of concern or higher.
Within two years of a chemical being designated as a high-concern endocrine disruptor, agencies with regulatory authority over it would have to develop regulations to reduce human exposure.
In a written statement, Kerry said: “We have a responsibility not just to inform Americans of the dangers, but to protect them from chemicals with the potential to cause serious illnesses from birth defects to cancer. It's just common sense.”
By Pat Rizzuto
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)